Avantor to sell clinical services business to Audax in $650M deal

Avantor to sell clinical services business to Audax in $650M deal
Avantor ticks higher amid takeover speculation
Avantor agrees to buy Masterflex business of Antylia Scientific in all-cash deal
5.35BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US05352A1007
CUSIP
05352A100
Sector
Healthcare
Industry
Medical Instruments & Supplies
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
8.24
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.81
Wall Street Target Price
10.58
EPS Estimate Current Year
0.79
EPS Estimate Next Year
0.85
EPS Estimate Current Quarter
0.1569
EPS Estimate Next Quarter
0.1954
Most Recent Quarter
-
Revenue TTM
6,552,200,192
Gross Profit TTM
2,105,200,000
EBITDA
932,899,968
Profit Margin
-8.42%
Return On Assets TTM
2.70%
Return On Equity TTM
-9.44%
Revenue Per Share TTM
9.646
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-0.81
Qtly Earnings Growth YOY
-33.30%
Trailing PE
0.00
Forward PE
8
Price Sales TTM
0.844
Price Book MRQ
0.9896
Enterprise Value Revenue
1
Enterprise Value EBITDA
79
186.80
3.50%300.68
1.08%106.59
1.05%44.79
0.72%149.31
0.11%185.00
0.00%205.02
-3.98%210.00
-1.98%74.09
-0.83%457.50
-0.11%